Goldman Sachs Upgrades Varian Medical (VAR) to Neutral on Stabilization

March 7, 2013 7:28 AM EST Send to a Friend
Get Alerts VAR Hot Sheet
Price: $81.56 -0.34%

Rating Summary:
    14 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 25 | New: 24
Trade VAR Now!
Join SI Premium – FREE
Goldman Sachs upgraded Varian Medical (NYSE: VAR) from Sell to Neutral with a price target of $79.00 (from $62.00).

The firm sees business fundamentals stabilizing and said consensus estimates are now reasonable. The radiation oncology market operating dynamics look to be reaching a bottom, according to the firm.

Goldman raised FY13 EPS from $4.09 to $4.10, FY14 from $4.57 to $4.80 and FY15 from $5.07 to $5.37.

For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.

Shares of Varian Medical closed at $72.01 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst EPS Change, Analyst PT Change, Upgrades

Related Entities

Goldman Sachs

Add Your Comment